DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,568,932
-$100,205 QoQ
Shares Held
38,270
-0.4% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2.60517376535145.ToString("F0")%
Shared 0.ToString("F0")%
None 97.39482623464855.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $379,217,691 across 26 Biotechnology names. REGN ranks #3 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
364,513 | $162,769,634 | |
| 2 | BNTX |
BioNTech SE
|
387,214 | $34,415,577 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
38,270 | $29,568,932 | |
| 4 | INVA |
Innoviva, Inc.
|
892,336 | $20,791,428 | |
| 5 | INCY |
Incyte Corp
|
183,834 | $17,302,454 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
567,115 | $15,884,891 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
213,363 | $14,536,421 | |
| 8 | EXEL |
Exelixis, Inc.
|
334,487 | $14,346,147 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,568,932 | 38,270 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,669,137 | 38,438 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $20,473,374 | 36,412 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $20,826,225 | 39,669 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,128,644 | 38,044 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,523,629 | 10,562 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $43,448,799 | 41,331 | Shares | Defined | 2026-05-04 | |
| 2024-06-30 | $48,398,878 | 46,049 | Shares | Defined | 2026-05-04 | |
| 2024-03-31 | $47,572,029 | 49,426 | Shares | Defined | 2026-05-04 | |
| 2023-12-31 | $41,616,012 | 47,383 | Shares | Defined | 2026-05-04 | |
| 2023-09-30 | $39,270,827 | 47,719 | Shares | Defined | 2026-05-04 | |
| 2023-06-30 | $37,868,493 | 52,702 | Shares | Sole | 2026-05-04 | |
| 2023-03-31 | $33,183,962 | 40,386 | Shares | Defined | 2024-05-17 | |
| 2022-12-31 | $21,836,613 | 30,266 | Shares | Defined | 2024-05-17 | |
| 2022-09-30 | $19,522,574 | 28,340 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,259,872 | 8,898 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,241,504 | 6,073 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $26,598,990 | 42,119 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $42,434,009 | 70,118 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $22,458,892 | 40,210 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $18,033,256 | 38,114 | Shares | Defined | 2026-05-04 | |
| 2020-12-31 | $14,105,362 | 29,197 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $20,288,664 | 36,244 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $23,670,635 | 37,955 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $19,974,967 | 40,908 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||